Stockreport

Data Supporting the Cardiovascular Safety of VIVUS’ Qsymia® Published in The Journal of Clinical Endocrinology & Metabolism

VIVUS  (VVUS) 
Last vivus earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vivus.com/node/5806
PDF CAMPBELL, Calif., Jan. 14, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced that results from a new stu [Read more]